CMM-204: Prolotherapy

Prolotherapy (CPT M0076) for musculoskeletal pain or instability (e.g., laxity, weakness) is considered experimental, investigational, or unproven and is not covered. The guideline lists no covered indications and specifies no required documentation or other approval criteria.

"Based on the lack of conclusive scientific evidence demonstrating the clinical efficacy of prolotherapy combined with the potential to expose individuals to adverse side effects or complications, t..."

Sign up to see full coverage criteria, indications, and limitations.